Drugs / GSK2584786A
last change Mar 2011 re-read 2 minutes ago

GSK2584786A

Vaccine

Developed for
influenza
Investigated by
GlaxoSmithKline

Trials 1 · a red edge is where a trial was stopped

20112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT01195779 Sep 2010 → Mar 2011 influenza GlaxoSmithKline Terminated No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as GSK2584786A ClinicalTrials.gov intervention name — accepted as the source's own label NCT01195779
Modality Vaccine “GlaxoSmithKline Biologicals' influenza vaccine GSK2584786A” NCT01195779
Route Intramuscular Intramuscular injections” NCT01195779